Tetrapeptide inhibitors of β-secretase
US7169759B1 · kind B1 · utility
0Cited by
4References
111Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2000 |
| Grant date | Jan 30, 2007 |
| Priority date | — |
| Expiry date | May 17, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Statine-derived peptide inhibitors of the β-secretase enzyme are provided which are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of Aβ peptide in a mammal. The compounds of the invention provide useful methods of treatment by administration of these inhibitors to reduce Aβ peptide formation and pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.